Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $72.05 USD
Change Today +0.45 / 0.63%
Volume 529.6K
MD On Other Exchanges
Symbol
Exchange
Mexico
Frankfurt
As of 8:04 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

mednax inc (MD) Snapshot

Open
$71.56
Previous Close
$71.60
Day High
$72.44
Day Low
$71.55
52 Week High
03/16/15 - $74.57
52 Week Low
10/15/14 - $49.82
Market Cap
6.7B
Average Volume 10 Days
577.0K
EPS TTM
$3.26
Shares Outstanding
93.5M
EX-Date
--
P/E TM
22.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDNAX INC (MD)

Related News

No related news articles were found.

mednax inc (MD) Related Businessweek News

No Related Businessweek News Found

mednax inc (MD) Details

MEDNAX, Inc., together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the United States and Puerto Rico. The company offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services. It also provides maternal-fetal care, including inpatient and office-based clinical care to expectant mothers and their unborn babies through maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians consisting of maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. The company’s pediatric cardiology care services comprise inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through pediatric cardiologist subspecialists and other related clinical professionals. In addition, it provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, and pediatric surgeons, as well as support services in the areas of hospitals, primarily in the pediatric emergency room, labor and delivery area, and nursery and pediatric departments. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida.

7,550 Employees
Last Reported Date: 02/9/15
Founded in 1979

mednax inc (MD) Top Compensated Officers

Co-Founder, Chief Executive Officer, Director...
Total Annual Compensation: $1.0M
President and Chief Operating Officer
Total Annual Compensation: $600.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $414.6K
President of American Anesthesiology
Total Annual Compensation: $500.0K
President of Pediatrix Medical Group
Total Annual Compensation: $450.0K
Compensation as of Fiscal Year 2014.

mednax inc (MD) Key Developments

MEDNAX Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Second Quarter Ending June 30, 2015

MEDNAX announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. Operating income for the 2015 first quarter was $114.8 million, up 10.3% from $104.1 million for the prior-year period. The company generated net income attributable to shareholders of $68.7 million for the 2015 first quarter, or $0.72 per diluted share based on a weighted average 95.3 million shares outstanding. This compares with net income attributable to shareholders of $63.7 million, or $0.63 per diluted share, for the 2014 first quarter, based on a weighted average 100.7 million shares outstanding, representing growth in diluted earnings per share of 14.3%. Net revenue for the three months ended March 31, 2015 increased by 12.9%, to $639.4 million, from $566.3 million for the prior-year period, driven by a mix of contributions from acquisitions completed since January 2014 and same-unit growth. 11% of this growth came from recent acquisitions with anesthesiology practices contributing roughly 60% of that growth and the remainder coming from non-practice acquisitions and pediatric specialty-related acquisitions. The company expects that its diluted earnings per share for the three months ending June 30, 2015, will be in the range of $0.85 to $0.89. The range for its second quarter guidance assumes anticipated same-unit revenue growth that will be flat to 2% higher year-over-year, including an approximately 2% unfavorable impact on pricing from the decrease in parity revenue from the 2014 second quarter. Excluding parity revenue from both periods, a non-GAAP measure, its second quarter outlook assumes same-unit revenue growth of 2% to 4% year-over-year. Included in its second quarter is approximately $0.01 of Medicaid parity, net of the impacts from incentive compensation expense and income taxes compared to $0.05 in last year's second quarter.

MEDNAX Seeks Acquisitions

MEDNAX, Inc. (NYSE:MD) is seeking acquisitions. Roger Medel, Mednax's Chief Executive Officer, said "Looking forward, we'll review our potential uses of capital, and I want to emphasize that our first priority for the use of capital is for acquisitions, but we will continue to consider share repurchases as an additional use of our capital in the future."

MEDNAX, Inc. to Report Q1, 2015 Results on Apr 30, 2015

MEDNAX, Inc. announced that they will report Q1, 2015 results at 10:00 AM, Eastern Daylight on Apr 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MD:US $72.05 USD +0.45

MD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $48.57 USD -0.03
DENTSPLY International Inc $52.57 USD +1.14
HealthSouth Corp $43.34 USD -0.17
Mettler-Toledo International Inc $324.04 USD +3.54
PerkinElmer Inc $52.06 USD -0.49
View Industry Companies
 

Industry Analysis

MD

Industry Average

Valuation MD Industry Range
Price/Earnings 21.9x
Price/Sales 2.7x
Price/Book 3.2x
Price/Cash Flow 18.0x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDNAX INC, please visit www.mednax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.